Nektar Therapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 16.09 M | $14.97 M | 0.77% | 7.69% |
| VANGUARD GROUP INC | 02/11/2025 | 12.33 M | $11.47 M | -6.04% | 5.89% |
| SAMLYN CAPITAL, LLC | 02/14/2025 | 9.67 M | $8.99 M | 5.08% | 4.62% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 7.81 M | $7.26 M | 90.02% | 3.73% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 7.20 M | $6.69 M | 27.34% | 3.44% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 6.65 M | $6.18 M | -29.26% | 3.18% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 5.54 M | $5.15 M | -6.29% | 2.65% |
| WOODLINE PARTNERS LP | 02/14/2025 | 4.97 M | $4.63 M | 187.27% | 2.38% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 4.52 M | $4.21 M | -10.60% | 2.16% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 4.00 M | $3.72 M | 0.00% | 1.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.96 M | $3.68 M | -0.14% | 1.89% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 3.91 M | $3.64 M | 17.52% | 1.87% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 3.00 M | $2.79 M | 26,172.00% | 1.43% |
| 22NW, LP | 02/14/2025 | 2.19 M | $2.04 M | 100.00% | 1.05% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2025 | 2.03 M | $1.89 M | 1.78% | 0.97% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 2.03 M | $1.89 M | 54.60% | 0.97% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.98 M | $1.84 M | -87.59% | 0.94% |
| UBS OCONNOR LLC | 02/14/2025 | 1.58 M | $1.47 M | 37.37% | 0.76% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.54 M | $1.43 M | 12.78% | 0.73% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 1.49 M | $1.38 M | -0.93% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.47 M | $1.36 M | 0.82% | 0.70% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.29 M | $1.20 M | -5.14% | 0.62% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.18 M | $1.10 M | 29.53% | 0.57% |
| 01/29/2025 | 1.11 M | $1.03 M | 100.00% | 0.53% | |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 1.02 M | $952,320 | 2.40% | 0.49% |
| ALMITAS CAPITAL LLC | 02/14/2025 | 920,225 | $855,809 | 0.00% | 0.44% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 833,256 | $774,928 | 66.12% | 0.40% |
| CM MANAGEMENT, LLC | 02/07/2025 | 750,000 | $697,500 | 0.00% | 0.36% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 730,875 | $679,714 | 12.30% | 0.35% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 727,386 | $676,469 | -59.21% | 0.35% |
| 02/14/2025 | 698,919 | $649,995 | 100.00% | 0.33% | |
| INVESCO LTD. | 02/13/2025 | 655,526 | $609,639 | 1.35% | 0.31% |
| EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 618,174 | $574,902 | 100.00% | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 555,876 | $516,965 | 59.29% | 0.27% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 522,409 | $485,840 | 10.42% | 0.25% |
| FMR LLC | 02/13/2025 | 514,364 | $478,359 | 33.03% | 0.25% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 493,639 | $459,222 | -2.10% | 0.24% |
| MACKENZIE FINANCIAL CORP | 02/20/2025 | 469,769 | $436,885 | 801.36% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 410,316 | $381,594 | 0.00% | 0.20% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 373,948 | $347,772 | 32.79% | 0.18% |
| SHAY CAPITAL LLC | 02/14/2025 | 352,204 | $327,550 | -77.92% | 0.17% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 326,716 | $303,846 | 0.00% | 0.16% |
| BARCLAYS PLC | 02/13/2025 | 325,818 | $303,000 | -9.06% | 0.16% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 312,693 | $290,804 | 30.92% | 0.15% |
| UBS GROUP AG | 02/14/2025 | 305,929 | $284,514 | 171.89% | 0.15% |
| MACQUARIE GROUP LTD | 02/14/2025 | 256,385 | $238,000 | 0.00% | 0.12% |
| XTX TOPCO LTD | 02/13/2025 | 244,701 | $227,572 | 595.77% | 0.12% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 192,978 | $180,000 | 6.01% | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 183,413 | $170,574 | 100.00% | 0.09% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 181,679 | $168,962 | 200.34% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nektar Therapeutics institutional Ownership - FAQ's
During the previous two years, 258 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 16.09 M
VANGUARD GROUP INC: 12.33 M
SAMLYN CAPITAL, LLC: 9.67 M
Nantahala Capital Management, LLC: 7.81 M
ACADIAN ASSET MANAGEMENT LLC: 7.2 M
EVENTIDE ASSET MANAGEMENT, LLC: 6.65 M
63.51% of Nektar Therapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 197.18 M shares in the last 24 months. This purchase volume represents approximately $230.70 M in transactions.